PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS. - Abdulla M; Alexsson A; Sundström C; Ladenvall C; Mansouri L; Lindskog C; Berglund M; Cavelier L; Enblad G; Hollander P; Amini RM (Acta oncologica (Stockholm, Sweden), 2021)